XML 60 R11.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2014
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share: Basic and diluted earnings per share from continuing operations for the three-month and six-month periods ended June 30, 2014 and 2013 are calculated as follows:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2014 |  | 2013 |  | 2014 |  | 2013
| (In thousands, except per share amounts)
Basic earnings per share from continuing operations |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income from continuing operations | $ | 89,404 |  |  | $ | 88,500 |  |  | $ | 155,408 |  |  | $ | 176,181 |
Net income from continuing operations attributable to noncontrolling interests | (6,932 | ) |  | (8,389 | ) |  | (14,584 | ) |  | (13,918 | )
Net income from continuing operations attributable to Albemarle Corporation | $ | 82,472 |  |  | $ | 80,111 |  |  | $ | 140,824 |  |  | $ | 162,263 |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares for basic earnings per share | 78,662 |  |  | 84,028 |  |  | 79,199 |  |  | 86,374 |
Basic earnings per share from continuing operations | $ | 1.05 |  |  | $ | 0.95 |  |  | $ | 1.78 |  |  | $ | 1.88 |
Diluted earnings per share from continuing operations |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income from continuing operations | $ | 89,404 |  |  | $ | 88,500 |  |  | $ | 155,408 |  |  | $ | 176,181 |
Net income from continuing operations attributable to noncontrolling interests | (6,932 | ) |  | (8,389 | ) |  | (14,584 | ) |  | (13,918 | )
Net income from continuing operations attributable to Albemarle Corporation | $ | 82,472 |  |  | $ | 80,111 |  |  | $ | 140,824 |  |  | $ | 162,263 |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares for basic earnings per share | 78,662 |  |  | 84,028 |  |  | 79,199 |  |  | 86,374 |
Incremental shares under stock compensation plans | 429 |  |  | 461 |  |  | 403 |  |  | 488 |
Total shares | 79,091 |  |  | 84,489 |  |  | 79,602 |  |  | 86,862 |
Diluted earnings per share from continuing operations | $ | 1.04 |  |  | $ | 0.95 |  |  | $ | 1.77 |  |  | $ | 1.87 |
On February 25, 2014, the Company increased the regular quarterly dividend by 15% to $0.275 per share. On May 13, 2014, the Company declared a cash dividend of $0.275 per share, which was paid on July 1, 2014 to shareholders of record at the close of business as of June 13, 2014. On July 14, 2014, the Company declared a cash dividend of $0.275 per share, which is payable on October 1, 2014 to shareholders of record at the close of business as of September 15, 2014. Under its existing Board authorized share repurchase program, on February 3, 2014, the Company entered into an accelerated share repurchase (ASR) agreement with Merrill Lynch International (Merrill Lynch), acting through its agent Merrill Lynch, Pierce, Fenner and Smith Incorporated, relating to a fixed-dollar, uncollared ASR program pursuant to which we purchased $50 million of our common stock from Merrill Lynch in two $25 million tranches. Pursuant to the terms of the agreement, Merrill Lynch immediately borrowed shares of Albemarle common stock that were sold to the Company, thereby decreasing the Company’s issued and outstanding shares (with no change to its authorized shares). On February 3, 2014, the Company paid $50 million to Merrill Lynch and received an initial delivery of 623,248 shares of our common stock with a fair market value of approximately $40 million. This purchase was funded with cash on hand. The Company determined that the ASR agreement with Merrill Lynch met the criteria to be accounted for as a forward contract indexed to its stock and was therefore treated as an equity instrument. Under the terms of the agreement, on April 30, 2014, the transaction was completed and we received a final settlement of 150,504 shares, calculated based on the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock over the term of the agreement, less a forward price adjustment amount of approximately $0.77. The total number of shares repurchased under this agreement (773,752 shares) reduced the Company’s weighted-average shares outstanding for purposes of calculating basic and diluted earnings per share during the three-month and six-month periods ended June 30, 2014. Under its existing Board authorized share repurchase program, on April 30, 2014, the Company entered into an ASR agreement with JPMorgan Chase Bank, National Association (JPMorgan), acting through its agent J.P. Morgan Securities LLC, relating to a fixed-dollar, uncollared ASR program pursuant to which we will purchase $100 million of our common stock from JPMorgan. The shares will be purchased by JPMorgan in two $50 million tranches that may be settled separately or simultaneously. Pursuant to the terms of the ASR Agreement, JPMorgan immediately borrowed shares of Albemarle common stock that were sold to the Company, thereby decreasing the Company’s issued and outstanding shares (with no change to its authorized shares). On May 1, 2014, the Company paid $100 million to JPMorgan and received an initial delivery of 1,193,317 shares of our common stock with a fair market value of approximately $80 million. This purchase was funded with cash on hand and commercial paper notes. The Company has determined that the ASR agreement with JPMorgan meets the criteria to be accounted for as a forward contract indexed to its stock and is therefore being treated as an equity instrument. Although the ASR agreement with JPMorgan can be settled, at the Company’s option, in cash or in shares of common stock, the Company intends to settle in shares of common stock. The initial delivery of 1,193,317 shares reduced the Company’s weighted average shares outstanding for purposes of calculating basic and diluted earnings per share for the three-month and six-month periods ended June 30, 2014. The total number of shares to ultimately be purchased under the ASR Agreement with JPMorgan will be determined at the completion of the trade and will generally be based on the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock over the term of the agreement. The Company evaluated the ASR agreement with JPMorgan for its potential dilution of earnings per share and has determined that, based on the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock calculated as of June 30, 2014, additional shares expected to be received upon final settlement (approximately 231,000 shares) would have an anti-dilutive impact on earnings per share and therefore were not included in the Company’s diluted earnings per share calculation for the three-month and six-month periods ended June 30, 2014. The final settlement amount may increase or decrease depending upon the daily Rule 10b-18 volume-weighted average prices of the Company’s common stock during the remaining term of the agreement. As announced on July 15, 2014, the Company and Rockwood Holdings, Inc. (“Rockwood”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which the Company will acquire Rockwood in a cash and stock transaction. Refer to Note 17, “Subsequent Events” for additional information about this transaction. Pursuant to the terms of the ASR Agreement with JPMorgan, the period over which the Rule 10b-18 volume-weighted average prices of the Company’s common stock is calculated has been suspended, effective as of the date of the Merger Agreement. Final settlement is expected to occur approximately twelve trading days after the later of (a) the completion of the transaction, or (b) the completion of any restricted period (as defined under Regulation M of the Exchange Act) related to the transaction. However, final settlement may be accelerated at the option of JPMorgan, and the number of shares to be delivered may be adjusted upon the announcement or occurrence of certain corporate events, including without limitation, tender offers, delisting, merger events or insolvency. Additionally, the ASR agreement with JPMorgan will be terminated at any time that our share price is at or below $33.50 per share. During the six-month period ended June 30, 2014, the Company repurchased a total of 1,967,069 shares of its common stock pursuant to the terms of its share repurchase program. As of June 30, 2014, there were 3,972,525 remaining shares available for repurchase under the Company’s authorized share repurchase program.

X
- Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration